Cetera Advisor Networks’s Bio-Rad Laboratories Class A BIO Stock Holding History

Cetera Advisor Networks’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$231K	Sell	668 -266	-28%	-$87.5K	﹤0.01%	2490
2023 Q4	$302K	Sell	934 -1,126	-55%	-$353K	﹤0.01%	2244
2023 Q3	$738K	Buy	2,060 +5	+0.2%	+$1.93K	﹤0.01%	1481
2023 Q2	$779K	Buy	2,055 +52	+3%	+$21.2K	0.01%	1415
2023 Q1	$959K	Buy	2,003 +71	+4%	+$33.2K	0.01%	1261
2022 Q4	$812K	Buy	+1,932	New	+$780K	0.01%	1304
2020 Q3	–	Sell	-201	Closed	-$91K	–	1406
2020 Q2	$91K	Buy	+201	New	+$88.7K	﹤0.01%	1569

Other funds holding BIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Cetera Advisor Networks's BIO Position: Q1 2024 in Review

Cetera Advisor Networks reduced its Bio-Rad Laboratories Class A (BIO) stake by 28% in Q1 2024, selling an estimated $87.5K and leaving 668 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #2490.

Cetera Advisor Networks first reported a position in BIO in Q2 2020 and has held it in 7 quarters since. The position peaked at $959K in Q1 2023. 467 funds tracked by Wall St. Rank hold BIO as of Q1 2024.

Cetera Advisor Networks held 668 shares of Bio-Rad Laboratories Class A worth $231K as of Q1 2024.
Cetera Advisor Networks sold 266 Bio-Rad Laboratories Class A shares in Q1 2024, an estimated $87.5K.
Bio-Rad Laboratories Class A made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #2490 holding.
Cetera Advisor Networks first reported a position in Bio-Rad Laboratories Class A in Q2 2020 and has held it in 7 quarters since.
Cetera Advisor Networks's Bio-Rad Laboratories Class A position peaked at $959K in Q1 2023.
467 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.